(ADCC) is the main mechanism of killing parasite larvae; whereas in mice, cytotoxicity in schistosomiasis requires activated macrophages.
In vitro cytotoxmity assays and in vivo passive transfer experiments show that ADCC systems consist of inflammatory cells (macrophages, eosmophils, platelets) tween the production of IgE against schistosomes and the acquisition of immunity during reinfection (7) . In Brazil, Molescents with high resistance to infection by S. mansoni have specific IgE levels that are six-to elghtfold higher than those with low resistance; other Ig isotypes are either similar in both groups or higher in the least resistant subjects (8) . More recently, the combination of low IgE antibodies to S mansoni with high IgG4 was associated with 100 times more susceptibility to reinfection than usual (8) . Similar observations have also been made in Kenya in a community infected by S. mansoni, again supportm g a role for IgE in preventing human infection by schistosomes (9 Surface antigens on the schistosomula of Schistosoma mansoni, the description of a second class of
The parasites were incubated with mouse monoclonal antibodies and IgE rdceptor, FceRII, on mononufluorescein-labeted antibody to mouse IgG. The staining was visual-clear phagocytes, eosinophils, and ized and analyzed by confocal laser microscopy, platelets (10) . T h e similarity between the B ceil differentiation anfirst in vivo evidence that IgE antibodies rigen CD23 and FcsRII, the cloning of could be an essential component of protecFceRII-CD23, and the availability of antirive immunity was provided by passive bodies to CD23 allowed tile demonstration transfer of monoclonal IgE molecules diof CD23, or CD23-related molecules, on rected against schistosomes (5, 6) . The inhuman eosinophiIs and platelets (11 ) . Variduction of resistance to infection by adopous antibodies to CD23, which bind to a tive transfer of eosinophils or platelets subpopulation of eosinophils and platelets, bearing cyrophilic IgE clearly indicated strongly inhibited cytotoxicity agamst that the IgE on these effector cells was cruschistosomula targets (11 ) . In contrast to cial (5) . These experimental observations FcsRI, which is constitutively expressed by are relevant to human immunity, as estabmast cells and basophils, FcsRII is detected lished by several seroepidemiological studmainly on activated ceils, the number of ies. In an area in Gambia endemic for S.
which increases in pathological and experihaematobium, a link was established bemental conditions associated with elevated lgE; the expression of the receptor could indeed be induced by ]gE (1 I). There are two forms of FceRIl-CD23: FcgRlla, which is developmentally regulated and expressed only on B cells; and Fc~Rllb, inducible in the other cell populations, including an eosinophilic cell line. These findings are consistent with the possibility that inducible FcCR]I-CD23 participates in the binding of ]gE to eosinophils. However, the low mRNA levels and membrane expression of Fc~:]l-CD23, together with the finding that a non-mast cell population, the Langerhans cell, can coexpress FcERII and Fc~'RI (I 2), raised the possibility that eosinophils and platelets also express Fc~:R]. Indeed, with monoclonal antibodies, the R chain of FceR] can be shown to be expressed by a subpopulation of human eosinophils and to be involved in IgE binding (13) , and the mRNAs for Fc~RI 0~, ~3, and T chains can be detected in eosinophil RNA extracts. Moreover, there is evidence that FcERI, able to induce a selective release of eosinophil granule proteins, can mediate eosinophil-dependent cytotoxicity against schismsomula (13), and similar findings have recently been obtained in blood platelets. Thus, in addition to its role in mediating allergic responses, Fc~'RI, expressed on eosinophils and platelets, may participate in a physiological protective immune response against schistosomes.
Besides IgE, soluble factors, mast cell mediators, or cytokines (I1-5, granulocytemacrophage colony-stimulating factor, or tumor necrosis factor (x) can upregulate the expression of IgE receptors, as well as IgEdependent cytotoxicity mediated by eosinophils. In addition, adhesion molecules, including integrins (CR3 on eosinophils or IlbllIa on platelets, S-type lectins (Mac2/e binding protein) or selectins have been implicated as accessory molecules, reinforcing the cytotoxic capacity of eosinophils or platelets and confirming the variety of interactions between effector cells and their parasite targets.
Although the respective functions of the various IgE receptors remain to be elucidated, their striking diversity is consistent with the effector role of IgE antibodies suggested by experimental observations and immunoepidemiological studies in human populations. In a broader context, IgE response in schistosomiasis and its role in protective immunity have to be regarded as part of a TH2-dependent regulatory circuit. In human populations, increased IL-5 is significantly associated with resistance to reinfection whereas, at least in this study, there was no correlation with interferon T (IF]q-T) production (14) . In addition to the ]gE response, there is an unsuspected association of specific IgA antibodies with acquisition of immunity (15) . There is therefore increasing evidence that protective immunity in human schistosomiasis is associated with TH2 rather than TH1 responses.
Whether a TH1 or TH2 response occurs is influenced by, among other fact&s, the number of exposures to antigen. In the mouse, cell-mediated mechanisms associated with TEl cell responses predominate in mice vaccinated once, whereas further immunizations stimulate TH2 cell responses, such as enhanced IgG1 production, that also contribute to protective immunity (16) . Thus, depending on the context, TH1 or TH2 responses can protect against infection with schistosomes, a result compatible with the protective role of IgG1 antibodies in mice (17) and the age-dependent acquisition of immunity after multiple exposures to parasite infection in humans (9) . Finally, it is now clear that muhiple cytokines can be secreted by cells other than TH1 or TH2 cells. Besides mast ceils, eosinophils, a pivotal cell population in the immune response to schistosomes, express the IL-5 gene and secrete IL-5 in response to various stimuli, among which are immune complexes with lgE and IgA (•8). Thus, there are regulatory networks independent of the TH1 and TH2 cells' cross-reactive circuits and, attractive as it may be, a simple dichotomy cannot account for the multiple facets of immunoregulation in schistosomiasis. The reasons why schistosomes, and other helminths like nematodes, preferably induce TH2 responses for protective immunity are not yet clearly defined. Interestingly, schistosomes release enzymes such as serine proteases that are able to potentiate IgE responses and secrete molecules such as adrenocorticotropic hormone or o~-melanocyte stimulating hormone, known to down-regulate ]FN-T production (19, 20) .
These observations go to the heart of vaccine strategies against schistosomiasis. Among several promising molecules, the S . mansoni glutathione-S-transferase (Sm28 GST) induces both IgE and ]gA antibodies. These antibodies are associated with protection in experimental models, as measured by worm burden reduction and decrease in parasite fecundity (21) . The more we improve our understanding of the immune response in human schistosomiasis, the more opportunities we create for the development of anti-schistosome and, maybe more generally, anti-helminthic vaccines.
